Invention Grant
- Patent Title: MANF2 for treatment of Parkinson's disease
- Patent Title (中): MANF2用于治疗帕金森病
-
Application No.: US12037535Application Date: 2008-02-26
-
Publication No.: US09127082B2Publication Date: 2015-09-08
- Inventor: Mart Saarma , Juha Lauren , Paivi Lindholm , Tonis Timmusk , Raimo Tuominen
- Applicant: Mart Saarma , Juha Lauren , Paivi Lindholm , Tonis Timmusk , Raimo Tuominen
- Applicant Address: FI Helsinki
- Assignee: HERANTIS PHARMA PLC.
- Current Assignee: HERANTIS PHARMA PLC.
- Current Assignee Address: FI Helsinki
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61P25/16 ; C12N15/86 ; C07K14/475 ; A61K38/00
Abstract:
The present invention discloses a novel neurotrophic factor protein, MANF2 and a genetic sequence encoding the same. The molecule will be useful in the development of a range of therapeutics and diagnostics useful in the treatment, prophylaxis and/or diagnosis of MANF2 dependent conditions. The molecule of the present invention is also a useful effector of primary and central neurons, especially dopaminergic neurons at the central nervous system and growth factor genes.
Public/Granted literature
- US20080269154A1 Novel neurotrophic factor protein and uses thereof Public/Granted day:2008-10-30
Information query
